Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study
The Lancet2019Vol. 394(10209), pp. 1629–1637
Citations Over TimeTop 1% of 2019 papers
Ron Waksman, Carlo Di Mario, Rebecca Torguson, Ziad A. Ali, Varinder Singh, William Skinner, Andre Artis, Tim ten Cate, Eric R. Powers, Christopher Kim, Evelyn Regar, S. Chiu Wong, S. R. Lewis, Joanna J. Wykrzykowska, Sandeep Dube, Samer Kazziha, Martin van der Ent, Priti Shah, Paige Craig, Quan Zou, Paul Kolm, H. Bryan Brewer, Héctor M. García‐García, Habib Samady, Jonathan M. Tobis, Mark Zainea, Wayne Leimbach, Daniel Lee, Thomas LaLonde, William Skinner, Augusto Villa, Henry Liberman, George Younis, Ranil de Silva, Miguel A. Diaz, Luis Tami, John McB. Hodgson, Ganesh Raveendran, Nilesh Goswami, Jose H Arias, Lawrence Lovitz, Robert V. Carida, Srinivasa Potluri, Francesco Prati, Andrejs Ērglis, Andrei Pop, Margaret McEntegart, Martin Hudec, Umamahesh C. Rangasetty, David E. Newby
Related Papers
- → Prospective Validation that Vulnerable Plaque Associated with Major Adverse Outcomes Have Larger Plaque Volume, Less Dense Calcium, and More Non-Calcified Plaque by Quantitative, Three-Dimensional Measurements Using Intravascular Ultrasound with Radiofrequency Backscatter Analysis(2013)17 cited
- → The impact of diabetes mellitus and hypertension on clinical outcomes in a population of Iranian patients who underwent percutaneous coronary intervention: A retrospective cohort study(2019)12 cited
- → [The impact of metabolic syndrome and its individual components on long-term prognosis of patients undergoing percutaneous coronary intervention].(2020)6 cited
- → DES Strut Thickness and Clinical Outcomes After CTO Recanalization: Insights From LATAM CTO Registry(2023)3 cited
- → ELEVATED SERUM FIBRINOGEN LEVEL IS ASSOCIATED WITH LONG-TERM MAJOR ADVERSE CARDIAC EVENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION(2015)1 cited